Notice2021-25413
Submission for OMB Review; 30-Day Comment Request; Federal COVID Response-Audience Feedback To Inform Ongoing Messaging and Strategies for “Combat COVID”
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Published
November 22, 2021
Issuing agencies
Health and Human Services DepartmentNational Institutes of Health
Abstract
In compliance with the Paperwork Reduction Act of 1995, the National Institutes of Health (NIH) has submitted to the Office of Management and Budget (OMB) a request for review and approval of the information collection listed below.
Full Text
<html>
<head>
<title>Federal Register, Volume 86 Issue 222 (Monday, November 22, 2021)</title>
</head>
<body><pre>
[Federal Register Volume 86, Number 222 (Monday, November 22, 2021)]
[Notices]
[Pages 66321-66322]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2021-25413]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Submission for OMB Review; 30-Day Comment Request; Federal COVID
Response--Audience Feedback To Inform Ongoing Messaging and Strategies
for ``Combat COVID''
AGENCY: National Institutes of Health, HHS.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: In compliance with the Paperwork Reduction Act of 1995, the
National Institutes of Health (NIH) has submitted to the Office of
Management and Budget (OMB) a request for review and approval of the
information collection listed below.
DATES: Comments regarding this information collection are best assured
of having their full effect if received within 30-days of the date of
this publication.
ADDRESSES: Written comments and recommendations for the proposed
information collection should be sent within 30 days of publication of
this notice to <a href="http://www.reginfo.gov/public/do/PRAMain">www.reginfo.gov/public/do/PRAMain</a>. Find this particular
information collection by selecting ``Currently under 30-day Review--
Open for Public Comments'' or by using the search function.
FOR FURTHER INFORMATION CONTACT: To request more information on the
proposed project or to obtain a copy of the data collection plans and
instruments, contact: Ms. Mikia P. Currie, Office of Policy for
Extramural Research Administration, 6705 Rockledge Drive, Suite 350,
Bethesda, Maryland 20892, or call a non-toll-free number (301) 435-0941
or Email your request, including your address to:
<a href="/cdn-cgi/l/email-protection#e1b1938e8b848295a28d848093808f8284a393808f8289a18c80888dcf8f8889cf868e97"><span class="__cf_email__" data-cfemail="bbebc9d4d1ded8cff8d7dedac9dad5d8def9c9dad5d8d3fbd6dad2d795d5d2d395dcd4cd">[email protected]</span></a>.
SUPPLEMENTARY INFORMATION: This proposed information collection was
previously published in the Federal Register on September 7, 2021, page
50143 (86 FR 50143) and allowed 60 days for public comment. No public
comments were received. The purpose of this notice is to allow an
additional 30 days for public comment. The National Institutes of
Health may not conduct or sponsor, and the respondent is not required
to respond to, any information collection that has been extended,
revised, or implemented on or after October 1, 1995, unless it displays
a currently valid OMB control number.
In compliance with Section 3507(a)(1)(D) of the Paperwork Reduction
Act of 1995, the National Institutes of Health (NIH) has submitted to
the Office of Management and Budget (OMB) a request for review and
approval of the information collection listed below.
Proposed Collection: Audience Feedback to Inform Ongoing Messaging
and Strategies for ``Combat COVID,'' OMB #0925-0769, exp., date 12/31/
2021, EXTENSION National Institutes of Health (NIH).
Need and Use of Information Collection: The purpose of the
information collection is to collect routine feedback from the Combat
COVID Initiative's two target audiences (the general public and
healthcare providers) to identify evolving needs and better disseminate
relevant information as it relates to COVID-19 treatment and
Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV)
clinical trial resources, specifically. Data collected will be used to
inform the development and broad dissemination of Combat COVID
resources, including new or enhanced message and material concepts
(e.g., social media ads, digital display ads, out-of-home ads), and/or
web pages (<a href="http://combatcovid.hhs.gov">combatcovid.hhs.gov</a>). Because the COVID-19 treatment
landscape continues to evolve, new evidence-based information continues
to come to the forefront, and audience needs continue to change, it is
critical for the Federal COVID Response (FCR) Team to collect quick
audience feedback from the general public (especially from groups who
have not historically been well-represented in clinical trials) and
healthcare providers to identify these evolving needs. By understanding
target audience needs, the FCR team will be able to properly develop
and broadly disseminate relevant COVID-19 treatment and ACTIV clinical
trial resources. A change request was recently submitted to update the
recall stimuli (still images, audio, and video or animated images) for
questions about exposure to the Combat COVID message and materials. It
also removed questions that are no longer relevant and replaced them
with more relevant questions about the latest COVID-19 treatment
options and clinical trials.
OMB approval is requested for 1 year. There are no costs to
respondents other than their time. The total estimated annualized
burden hours are 3,528.
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Number of Average time
Form name Number of responses per per response Total annual
respondents respondent (in hours) burden hours
----------------------------------------------------------------------------------------------------------------
Consumer Audience Feedback Team Screener........ 120 1 5/60 10
HCP Audience Feedback Team Screener............. 40 1 5/60 3
Consumer Audience Feedback Activity............. 60 8 1 480
HCP Audience Feedback Activity.................. 20 8 1 160
[[Page 66322]]
Benchmark & Follow-Up Web Surveys--Consumer 2,000 5 15/60 2,500
Audience.......................................
Benchmark & Follow-Up Web Survey--HCP Audience.. 300 5 15/60 375
---------------------------------------------------------------
Total....................................... 2,540 12,300 .............. 3,528
----------------------------------------------------------------------------------------------------------------
Dated: November 16, 2021.
Lawrence A. Tabak,
Principal Deputy Director, National Institutes of Health.
[FR Doc. 2021-25413 Filed 11-19-21; 8:45 am]
BILLING CODE 4140-01-P
</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>Indexed from Federal Register on November 22, 2021.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.